Enanta Pharmaceuticals Inc

NASDAQ:ENTA   10:55:20 AM EDT
76.56
-1.10 (-1.42%)
Earnings Announcements

Enanta Pharmaceuticals Q4 Loss Per Share $1.22

Published: 11/22/2021 22:06 GMT
Enanta Pharmaceuticals Inc (ENTA) - Q4 Loss per Share $1.22.
Qtrly Revenue $23.6 Million Versus $23.6 Million.
Sees FY 2022 Research and Development Expense in the Range of $150 Million to $170 Million.
Sees FY 2022 General and Administrative Expense in the Range of $35 Million to $41 Million.
Revenue is expected to be $27.39 Million
Adjusted EPS is expected to be -$1.13

Next Quarter Revenue Guidance is expected to be $23.01 Million
Next Quarter EPS Guidance is expected to be -$1.33

More details on our Analysts Page.